Evaluating the Implementation of a Comprehensive Multilevel Virtual Oncology Program Among Veterans Diagnosed With Lung, Colorectal, Prostate, and Breast Cancers in the US Department of Veterans Affairs

ConditionsLung Cancer Diagnosis Colorectal Cancer (Diagnosis)Prostate Cancer Diagnosis Breast Cancer Diagnosis

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18+

SponsorNYU Langone Health

About this trial

The objective of the pragmatic trial to test the effectiveness of an existing, ongoing clinical service, the VA National TeleOncology program (NTO), a multilevel telehealth population health management program. The primary aims are to study the intervention and determine its effectiveness on telehealth engagement, clinical quality, and healthcare cost outcomes across personal characteristics.

Eligibility criteria

Qualifiers

A Veteran

Aged 18 years or older

Newly diagnosed with lung, prostate, breast, or colon cancer within 3 months of telemedicine visit

Engaged in an oncology visit during the 36-month analysis period at a Veterans Affairs Medical Center (VAMC) location.

Disqualifiers

Veterans who have not seen any providers in the VA within the past year

Patients previously diagnosed with lung, prostate, breast, or colon cancer

Pregnant patients

Trial design

Treatments tested in this trial

National TeleOncology

Treatment groups

1,800 Participants

are divided into 2 treatment groups

Locations

VA New York Harbor Healthcare System - Brooklyn11209, BrooklynNew York, United States

VA New York Harbor Healthcare System - St. Albans Community Living Center11425, JamaicaNew York, United States

VA New York Harbor Health Care System - Manhattan10010, New YorkNew York, United States

VA New York Harbor Healthcare System - Harlem Community Center10027, New YorkNew York, United States

Sponsors and collaborators

NYU Langone Health

Lead sponsor

National Cancer Institute (NCI)

Collaborator

Source ClinicalTrials.gov